Regenerative medical devices group Tissue Regenix has named Steve Couldwell as Chief Executive Officer of the Group, with immediate effect.

Steve has been in the position of non-executive director since July 2013, and has over 25 years’ experience in the pharmaceutical and medical device industry as well as “a proven track record of delivering revenue and profit growth”.